from pneumonia to bacteremia and indicates that a direct interaction occurs between the intact organism and the microvascular endothelium.
S. pneumoniae has many virulence factors implicated in the pathogenesis of pneumococcal disease, including pneumolysin, an intracellular thiol-activated toxin with cytolytic and complement-activating properties (3, 19) . Pneumolysin-negative mutants demonstrate reduced virulence in mice after intranasal challenge or intraperitoneal delivery. Effects of pneumolysin on host cells may be either direct (i.e., pore formation in host cell membranes) and/or indirect (i.e., activation of the complement system) (8, 14) . In a murine model of bronchopneumonia, pneumolysin-negative mutants had reduced survival in the lungs during the onset of pneumonia and decreased invasion and survival in the bloodstream. The host response to these mutants was muted, with reduced neutrophil influx and diminished inflammatory response (11) . However, whether this reflected simply a decrease in the severity of infection because of reduced bacterial growth or also a specific impairment in the induction of polymorphonuclear leukocytes (PMN) migration and accompanying inflammation could not be discerned. In addition, purified pneumolysin delivered into the lungs via intranasal inoculation in a murine model elicited a dosedependent influx of PMNs with accompanying inflammatory response (24) .
Neutrophil migration from the vascular space to the air space is an early and prominent component of the host innate response to pneumococcal invasion (17) , and the pneumococcalendothelial cell interactions that influence neutrophil transendothelial migration have not been well defined. However, recent data indicate that neutrophil recruitment to the lung and the early development of bacteremia were specifically influenced by the cytolytic activity of the toxin pneumolysin (10) .
The present study has focused specifically on interactions between the intact pneumococcus and the pulmonary microvascular endothelium and the role of the virulence factor pneumolysin in eliciting neutrophil transendothelial migration. Using our in vitro transmigration model, we demonstrate that pneumolysin is required to induce the maximal neutrophil transendothelial migratory response. Effects of pneumolysin are most clearly manifest during direct exposure of the endothelium to intact pneumococci and not through secretion of bacterial products into the surrounding media. Both pneumolysin-deficient mutants and the wild-type D39 adhere to and translocate across the endothelium to a similar extent and induce similar secretion of the neutrophil chemokine IL-8 by the endothelial monolayer. Neither strain elicits translocation of NF-B to the nucleus, nor is there upregulation of the endothelial adhesion molecules ICAM-1, VCAM-1, or E-selectin. The role of pneumolysin in pneumococcus-induced neutrophil transmigration appears to require a complex interaction between the bacteria, the neutrophil, and the endothelium.
MATERIALS AND METHODS
Human PMN purification. Human PMNs were isolated according to standard techniques from heparin anticoagulated venous blood from healthy consenting adults in accordance with a protocol approved by the Institutional Review Board for Human Subjects at the University of Iowa. PMN were isolated using dextran sedimentation and Hypaque-Ficoll density-gradient separation, followed by hypotonic lysis of erythrocytes as previously described (4) . Purified PMNs were resuspended in 0.9% saline before use in migration experiments.
Endothelial cell culture. Pulmonary microvascular endothelial cells (PMVEC) were purchased from Clonetics (San Diego, CA) and cultured on collagen-coated flasks (type VI, human placental collagen; Sigma, St. Louis, MO) using endothelial growth medium-2 (Clonetics) with added bovine brain extract, VEGF, EGF, gentamicin, and hydrocortisone according to manufacturer's specifications. Cells were received from Clonetics at passage 5 and used between passages 5 and 9. Cells were passed from T-75 flasks into experimental plates when ϳ70 -80% confluent. PMVEC were detached using trypsin-EDTA and cultured on collagen-coated Transwell (Costar, Cambridge, MA) 12-mm filters (transmigration experiments), Transwell 24-mm filters (immunofluorescence microscopy), or 96-well plates (whole-cell ELISA). Cell monolayers on Transwell filters were monitored by measuring resistance changes across the endothelial cell monolayer using an End Ohm epithelial voltohmeter (World Precision Instruments, Sarasota, FL). The microvascular endothelial cell monolayers reached an average resistance of 34 -37 ⍀/cm 2 across the monolayer within 5-6 days. Medium was changed on the monolayer every 48 h.
Bacterial cell cultures. S. pneumoniae serotype-2 strain D39 and its isogenic pneumolysin-negative mutant plnA Ϫ (gifts from Elaine Tuomanen, St. Jude Children's Research Hospital) were stored at Ϫ80°C, and an aliquot was streaked on blood agar plates 16 h before use. The serotype 2 D39 pneumolysin-negative mutant complemented with reinsertion of the pneumolysin gene (Pnϩ) and the purified pneumolysin toxin were gifts of Dr. Timothy Mitchell (University of Glasgow, Glasgow, Scotland). Bacteria were resuspended in endothelial basal medium (EBM), and bacterial concentration was determined by measuring optical diameter at 520 nm. Bacteria were added to the Transwell lower chambers at known optical diameter, and samples from time 0 and at 4 h (just before addition of the PMNs) were plated for colony-forming unit (CFU) determination to determine the growth of each bacterium during the initial 4-h bacteria/endothelial cell incubation.
In certain experiments, bacteria were EtOH fixed or heat killed before use in transmigration studies. EtOH fixation was performed by placing an aliquot of the strain in 70% EtOH on ice for 30 min, and organisms were heat killed by incubation at 65°C for 20 min. Plating of the samples on blood agar plates confirmed that EtOH and heat treatment eliminated all viable bacteria.
PMN transendothelial migration. We performed migration assays across PMVEC monolayers using a Transwell system (Fig. 1) as previously described. (16) The endothelial cells were not activated with serum or cytokines before the transmigration assay. Transwell filters with attached endothelial cell monolayers were transferred to clean 12-well plates and washed twice with HBSS. After removal of the HBSS, 400 l of EBM (Clonetics) was added to the Transwell filter compartment. Intact bacteria were added to the lower compartment in a total volume of 1 ml and incubated with the endothelial cells for 4 h at 37°C (except in time course studies, where timing is specified in RESULTS). At the end of this 4-h incubation, 10-l samples were removed from the lower chamber for quantitation of the bacterial CFU, and 2 ϫ 10 6 PMNs were added to the Transwell (upper chamber) in a volume of 100 l. PMNs were allowed to migrate over a 3-h period at 37°C. At the conclusion of the incubation, migrated cells were collected from the lower chamber for counting in a hemacytometer in triplicate. In preliminary experiments, PMNs recovered from above and below the endothelial monolayer accounted for ϳ90% of the initial number added, indicating that relatively few PMN were trapped within or in transit across the endothelium at any time examined. Therefore, percent PMN transmigration was calculated simply by dividing the number of PMN recovered from the lower chamber by the number of PMN initially added.
Bacterial translocation across the endothelial monolayer. Transwell filters with attached endothelial cell monolayers were transferred to clean 12-well plates and washed twice with HBSS. After removal of the HBSS, 400 l of EBM (Clonetics) was added to the Transwell filter upper compartment. Bacteria (D39 or plnA Ϫ ; 3 ϫ 10 6 ) were added to the lower compartment in a total volume of 1 ml and incubated with the endothelial cells at 37°C. No bacteria were added to the upper chamber of the Transwell. Aliquots (50 l) were removed from the upper and lower chambers of the Transwell at 1, 2, 4, and 6 h after the initial inoculum was added to the lower chamber and used for enumeration of CFU. The number of bacteria translocating to the upper chamber was expressed as a percentage of the initial inoculum in the lower chamber, and the CFU per milliliter present in the lower chamber over the time course studied is given for comparison to account for bacterial growth during the course of the assay.
Analysis of chemokine expression. Supernatants from the both the upper and lower chambers of the Transwell system during transmigration experiments were collected after PMN migration and filtered to remove bacteria and neutrophils before storage at Ϫ20°C. Levels of IL-8, monocyte chemoattractant protein (MCP)-1, regulated on activation normal T-expressed and presumably secreted (RANTES), IL-6, growth-related oncogene (GRO)-␣, and TNF-␣ were assayed in the supernatant using standard ELISA techniques. Briefly, 96-well plates were coated with a monoclonal antibody to the protein of interest (R&D Systems). Samples (50 l) from the collected supernatant were added to the plate followed by a biotinylated detection antibody. Fig. 1 . In vitro transmigration model. Pulmonary microvascular endothelial cells (PMVECs) were grown on a Transwell filter until peak electrical resistance signaling formation of a monolayer. Bacteria were then added to the lower chamber (abluminal surface) and incubated at 37°C, 5% CO2, and 95% relative humidity for 4 h; this was followed by addition of polymorphonuclear leukocytes (PMNs) to the upper chamber (luminal surface).
HRP-conjugated streptavidin (Pierce Chemicals) was then added to the plate, followed by a color substrate TMB (Sigma). Standard curves were made using recombinant protein for each of the proteins of interest (R&D Systems). Absorbance at 450 nm was read, and protein concentrations of unknown samples were extrapolated based on the standard curve.
Assays of surface expression of endothelial cell adhesion molecules. To assess endothelial cell surface expression of adhesion molecules, monolayers were grown on 6.5-mm Transwell filters to peak resistance as previously described. Whole bacteria or TNF-␣ (10 ng/ml) was added to the lower chamber of the Transwell apparatus and incubated for 6 h. At the completion of the incubation, cells were washed twice with HBSS and then blocked for 30 min with HBSS containing 0.5% BSA. In ELISA for E-selectin, cells were then fixed with 0.5% glutaraldehyde at 4°C for 30 min, before addition of the primary antibody. In ELISA for ICAM-1 and VCAM-1, primary antibody was added immediately after the blocking step. Primary antibodies were added 100 l/well, diluted in PBS ϩ 0.1% BSA, and incubated for 1 h at room temperature on a rotating shaker. The primary antibodies used were E-selectin (2 g/ml) (BD Pharmingen, San Diego, CA), ICAM-1 (0.375 g/ml) (Clone 6.5B5, Dako, Glostrup, Denmark), and VCAM-1 (0.5 g/ml) (BD Pharmingen). After this incubation, cells were washed five times with HBSS/0.1% BSA and incubated with peroxidase-conjugated goat anti-mouse secondary antibody (dilution of 1:1,000) for 1 h at room temperature. After the secondary antibody, cells were washed an additional five times, and liquid TMB substrate (Sigma) was added. Optical density at 650 nm was read after 30 min. For each ELISA, an isotype-matched control Ab was used in place of the primary antibody in three wells, and this background was subtracted from the signal.
Assessment of nuclear translocation of NF-B by microscopy. PMVEC were grown on Transwell 24-mm filters (Costar) to peak resistance. Filters with attached endothelial cells were rinsed twice with HBSS. After removal of the HBSS, 1,500 l of EBM (Clonetics) was added to the Transwell filter compartment. Bacteria suspended at the described concentrations in EBM or TNF-␣ (10 ng/ml) (positive control) were added to the lower compartment in a total volume of 2.5 ml and coincubated for 1-6 h at 37°C. After the incubation, filters were washed twice with PBS, fixed with 2% paraformaldehyde at room temperature for 20 min, permeabilized with 0.1% Triton for 10 min at room temperature, and blocked overnight with PBS ϩ 0.5% BSA. Primary antibody (anti-NF-B p65, 1:25) was applied to the luminal surface of the endothelial cells on the filter for 1 h at room temperature (Santa Cruz Biotechnology). After cells were washed three times with PBS ϩ 0.5% BSA, Texas red labeled goat anti-mouse Ab (Molecular Probes, Eugene, OR) was applied (1:1,000 dilution) for 1 h at room temperature. Specificity of staining was assessed by use of isotype control mouse antibodies (Sigma). Filters were washed and mounted on glass slides. Samples were viewed using a Zeiss Axioplan2 photomicroscope (Carl Zeiss, Thornwood, NY), and digital images were obtained using a Zeiss AxioCam and AxioVision 3.1 software.
Statistical analysis. Differences between experimental groups with paired comparisons composed of normally distributed data were analyzed for statistical significance using Student's t-test. Differences among groups of three or more data points were analyzed by ANOVA. Nonparametric evaluation of data sets was performed using the Mann-Whitney rank sum test.
RESULTS

Pneumolysin-dependent transmigration of PMN across
PMVECs. PMN migration across intact PMVEC monolayers was assessed for resting PMVEC monolayers and in response to several concentrations of intact, live S. pneumoniae or purified pneumolysin. In the absence of added bacteria or other stimulus, there was minimal migration of PMNs across the intact endothelial monolayer (Ͻ10,000 cells or Ͻ0.5% of the added PMNs). Live S. pneumoniae (serotype 2, D39) added at the abluminal surface of an intact endothelial monolayer potently elicited neutrophil migration, in a dose-dependent manner, across the monolayer in a luminal to abluminal direction. In contrast, an isogenic pneumolysin-deficient mutant (plnA Ϫ ) was markedly less potent in inducing PMN transmigration. Complementation of the mutant strain by reinsertion of the pneumolysin gene (Pnϩ) restored the ability of the organism to elicit PMN transmigration (Fig. 2) . Time course studies were performed to determine whether the reduced migration in response to the pneumolysin-deficient mutant simply reflected a delay in the onset of migration. After addition of 5 ϫ 10 6 CFU of each strain to PMVEC monolayers, there was reduced PMN migration in response to plnA Ϫ at all time points (Fig. 3) , indicating that the decrease in the number of PMNs transmi- Fig. 2 . Migration of human neutrophils across a PMVEC monolayer in response to intact, live Streptococcus pneumoniae: encapsulated, serotype 2 D39 vs. isogenic pneumolysin-deficient mutant, plnA Ϫ vs. the pneumolysindeficient strain complemented with reinsertion of the pneumolysin gene Pnϩ. X-axis represents bacterial colony-forming units (CFUs) present in lower chamber of the Transwell system at the time PMNs were added to the assay, after 4-h bacterial coincubation with the endothelial monolayer. The parent strain D39 potently elicited PMN transendothelial migration in a dose-dependent manner to a much greater extent than plnA Ϫ . Complementation of the deficient strain with reinsertion of Pnϩ restored migration to levels similar to the those for the parent strain. *P Յ 0.05 compared with D39; n ϭ 6 experiments. grating in response to the mutant organism did not reflect simply a delay in onset of the migratory response.
To provide further evidence of the role of pneumolysin in neutrophil migration elicited by pneumococci, we investigated migration in response to EtOH-fixed or heat-killed organisms. Purified pneumolysin is unaffected by EtOH treatment but is heat labile (28) . The difference in neutrophil migration in response to D39 vs. plnA Ϫ was also seen in ethanol-fixed bacteria, but overall transmigration of PMN was substantially decreased. Very few neutrophils migrated in response to either of the strains after heat killing (Fig. 4) . These findings are consistent with an important role of pneumolysin in pneumococcal-induced PMN transmigration and also suggest a need for intact, live pneumococci to induce the greatest response.
Role of bacterial products in eliciting migration. To determine whether pneumolysin acts independently as a secreted/ released bacterial product, we tested the ability of purified pneumolysin to elicit neutrophil transmigration in the absence of intact bacteria. Purified pneumolysin at 30 ng/ml (pneumolysin equivalent to 10 4 CFU of D39) (32) elicited neutrophil migration of 4.3% of the added PMNs. There was an increase in the number of PMNs migrating in response to higher concentrations of the purified toxin to a maximum migration of 29% of added PMNs in response to 3 g/ml of pneumolysin, with a decrease in migration at higher doses of pneumolysin (Fig. 5) . Inspection of the monolayer by immunofluorescence microscopy after incubation with concentrations of purified pneumolysin of 0.3-30 g/ml demonstrated significant dosedependent destruction of the architecture of the endothelial monolayer that was not seen in response to any of the concentrations of intact organisms studied (data not shown). In addition, electrical resistance across the monolayer declined to Ͻ10% of the starting value after incubation with these doses of pneumolysin. These data suggest that the action of pneumolysin in pneumococcus-induced PMN transmigration does not occur independently of the bacterial cell and support the contention that host cell responses to intact bacteria may change quantitatively, and perhaps qualitatively, from that induced, even by highly potent, isolated products of the bacteria.
Although pneumolysin is a cytosolic protein, it acts on host cells and therefore presumably depends on release of pneumolysin from the intact bacterial cell (e.g., lysis of pneumococci). We also tested the ability of conditioned media from each of the two strains (D39 and plnA Ϫ ) to induce neutrophil transmigration. The conditioned media were obtained by culturing live bacteria for 6 h in the endothelial medium used for transmigration studies, followed by filtration (0.2 M, lowprotein binding) to remove intact bacteria before addition of the media to the lower chamber (abluminal surface) of the Transwell apparatus. In addition, intact plnA Ϫ were supplemented with conditioned medium from D39 to determine whether soluble/secreted products released from the wild-type strain could enhance the PMN transmigration response induced by intact pneumolysin-deficient mutants. Neither the conditioned medium from D39 nor that from plnA Ϫ elicited PMN migration to the extent induced by the intact bacteria (Fig. 6) . Incubation of the monolayer with live plnA Ϫ combined with conditioned medium from D39 also did not elicit migration of PMN at a greater level than that seen with the mutant bacteria alone (Fig. 6) . These results suggest that the effects of pneu- Fig. 4 . Neutrophil transmigration across PMVEC monolayer in response to live, EtOH-fixed (70% EtOH on ice for 30 min) or heat-killed (65°C for 20 min) D39 or plnA Ϫ . Initial inoculum for both strains before described treatment was 3 ϫ 10 6 CFU/ml. Both live and EtOH-killed D39 elicited substantially greater PMN migration than an equivalent number of pneumolysindeficient organisms. Heat-killed bacteria of either strain elicited very little PMN migration. ૺP Յ 0.05 compared with D39; n ϭ 3 experiments, with 12 Transwells/condition. Fig. 5 . Neutrophil transendothelial migration in response to purified pneumolysin incubated in the abluminal compartment of the Transwell system. There was a dose-dependent induction of PMN transendothelial migration in response to concentrations of pneumolysin from 30 ng/ml to 3 g/ml but a decline in migration at higher concentrations of the toxin; n ϭ 6 experiments. Fig. 6 . Neutrophil transendothelial migration in response to intact, live bacteria or conditioned medium (CM) from each of the strains. CM was obtained by 6-h culture of the live bacteria in endothelial basal medium at 37°C, followed by filtration to remove intact bacteria. CM from both strains elicited substantially less PMN migration than intact organisms. CM from D39 coincubated with intact, live plnA Ϫ did not increase neutrophil migration above that seen with plnA Ϫ alone. ૺP Յ 0.05 compared with D39; n ϭ 4 experiments.
molysin require a more complex interaction between pneumococci and the endothelium to elicit PMN transmigration.
Bacterial translocation across the monolayer. One possible reason for enhanced PMN transmigration-inducing effects of live pneumococci is the need for bacteria to infect and translocate across the endothelium to have their greatest effect. To begin to address this possibility, we first examined growth and translocation of wild-type and mutant pneumococci across the endothelial monolayer in an abluminal to luminal direction. The upper and lower chambers of the Transwell system were sampled at 1, 2, 4, and 6 h after addition of bacteria to the lower chamber at time 0. Both D39 and plnA Ϫ were cultured from the upper chambers of their respective Transwells within 1 h of addition of the bacteria to the lower chamber, and the number in the upper chamber steadily increased over several hours. At 6 h, the number of D39 translocated to the upper chamber had further increased to 24.1 Ϯ 1.6% of CFU count in the lower chamber; however, translocation of the pneumolysindeficient mutant appeared to have plateaued (Fig. 7) . These data indicate that not only was there direct interaction of the S. pneumoniae at the abluminal surface of the endothelial monolayer, but bacterial translocation was occurring throughout our migration assays.
The integrity of the monolayer was assessed during many of these studies by measurement of the electrical resistance across the monolayer before and after incubation with the bacterial stimulus. The measured resistance across the monolayer after a 4-h incubation with 1 ϫ 10 6 live D39 declined by 23% and by 21% after incubation with heat-killed S. pneumoniae but remained significantly elevated over the resistance across the filter alone. The similar decrement in resistance after exposure to live vs. heat-killed D39 despite significantly greater PMN migration in response to the live organisms indicate that the PMN migration elicited is not simply a result of destruction of the monolayer. These data taken together with the studies of bacterial translocation suggest an active role of the endothelial monolayer in the interaction with the live bacteria and in eliciting PMN transmigration.
Role of chemokines in eliciting transmigration. Although bacterial translocation appears to occur during pneumococcalendothelial cell interaction in vitro, it did not require pneumolysin and thus is not an explanation for the disparity in neutrophil migration. We investigated the role of several chemokines that are expressed and secreted by the endothelium in response to inflammatory stimuli to determine whether differential expression was elicited by the two strains of bacteria. Both strains of bacteria potently induced IL-8 secretion at both the luminal (Fig. 8A) and abluminal (Fig. 8B) surfaces of the endothelial monolayer in a dose-dependent manner. When normalized for CFU count, the magnitude of IL-8 secretion was very similar in response to D39 and plnA Ϫ . In addition, there was greater secretion of IL-8 into the luminal compartment than into the abluminal compartment for several of the concentrations of bacteria studied. Together, these data suggest that IL-8 is not the primary mediator responsible for eliciting neutrophil migration under the conditions studied. There were not detectable levels of MCP-1, IL-6, or GRO-␣ elicited in response to either strain of S. pneumoniae. RANTES was produced in response to both D39 and plnA Ϫ at similar levels (data not shown). In addition, the cytokine TNF-␣ was measured as a potential neutrophil product that might be generated in response to neutrophil-bacterial interactions and perpetuate the migratory response. However, levels of TNF-␣ were undetectable in both the luminal and abluminal compartments in response to both strains of S. pneumoniae.
Expression of endothelial cell adhesion molecules. Neutrophil migration into the lung in response to S. pneumoniae utilizes both CD18-dependent and -independent pathways. We Fig. 7 . Bacterial translocation across an intact monolayer of PMVEC. D39 and plnA Ϫ both translocated in the abluminal to luminal direction across an intact endothelial monolayer within 1 h of addition to the lower chamber of the Transwell. There was a relative increase in the number of bacteria translocated to the upper chamber at each time point from 1 to 4 h for both D39 and plnA Ϫ . At 6 h after the initial inoculum was added, the number of D39 in the upper chamber had further increased to 24% of the CFU count in the lower chamber, whereas the translocation of plnA Ϫ appeared to have plateaued. Results for number of translocated bacteria (upper chamber) are expressed as a percentage of the CFU count in the lower chamber at the same time point. ૺP Յ 0.05 compared with plnA Ϫ ; n ϭ 4 experiments. investigated the surface expression of several endothelial cell adhesion molecules that might participate in neutrophil adhesion and transmigration and might be differentially upregulated in the presence or absence of the bacterial virulence factor pneumolysin. There was constitutive surface expression of ICAM-1 but no increase in surface levels after incubation of the monolayer with either D39 or plnA Ϫ (Fig. 9A) . Similarly, there was no upregulation of VCAM-1 or E-selectin by either strain (Fig. 9, B and C) , similar to our previous findings using a type 3 pneumococcal strain.(16) TNF-␣ (10 ng/ml) was used as a positive control and elicited significant upregulation of ICAM-1, VCAM-1, and E-selectin consistent with previously published data (20) .
Assessment of nuclear translocation of NF-B in response to S. pneumoniae. In view of the lack of upregulation of any of these adhesion molecules by S. pneumoniae, we explored whether NF-B had any role in pneumococcal activation of the endothelial monolayer. Although it has been previously demonstrated that certain strains of S. pneumoniae may elicit activation of NF-B (1, 18), this activation process by pneumococci appears to be restricted to certain host cell types (27) . PMVEC monolayers were incubated with D39 or plnA Ϫ for time points ranging from 1 to 6 h followed by fixation, permeabilization, and immunostaining for NF-B. There was no evidence of translocation of NF-B p65 to the nucleus in any of the monolayers exposed to S. pneumoniae (using CFU counts ranging from 1 ϫ 10 6 /ml to 5 ϫ 10 7 /ml) (data not shown). TNF-␣ (10 ng/ml) was used as a positive control and elicited nuclear translocation of p65 in Ͼ90% of the cells of the monolayer at 1, 2, 4, and 6 h of stimulation, consistent with previously reports (22) .
DISCUSSION
The intensely inflammatory neutrophilic infiltrate that accompanies pneumococcal pneumonia is responsible for significant host tissue damage, which contributes to morbidity. The role of pneumolysin in pathogenicity has primarily been studied with animal models with intranasal infection, instillation of purified pneumolysin (24) , or intratracheal administration of live bacteria. The requirement for pneumolysin in the pathogenesis of bronchopneumonia is well established (10, 11) . With the use of endotracheal instillation of bacteria, the pneumolysin-deficient mutant has been demonstrated to have reduced capacity to separate tight junctions of the alveolar epithelium and thus an inability to penetrate the alveolar capillary barrier and invade into the interstitial space (26) . These data suggest that the reduced virulence associated with pneumolysin deficiency may be attributable to an altered interaction at the alveolar epithelium.
Interactions between intact pneumococci and host cells occurring after penetration of the alveolar epithelium are also highly relevant to the pathogenesis of pneumococcal pneumonia, as this organism has been demonstrated to move across the respiratory epithelium by transcytosis (17) and invade the bloodstream, causing bacteremia (6, 29) . In the present investigation, the pneumolysin-deficient mutants are presented at the abluminal surface of the endothelium, as would occur when an organism has already successfully traversed the epithelium and interstitium. In this study, we demonstrate the potent induction of neutrophil transendothelial migration across a pulmonary microvascular endothelial monolayer in response to intact S. pneumoniae (serotype 2, D39) and a marked reduction in neutrophil migration elicited in response to the pneumolysindeficient mutant plnA Ϫ . The PMN migratory response occurred in a dose-dependent manner, with 10 5 wild-type bacteria eliciting significant migration and a plateau in the response with 5 ϫ 10 6 bacteria. The peak migration to the parent strain D39 included Ͼ55% of the PMNs, but only one-quarter of the PMNs migrated to a similar inoculum size of plnA Ϫ . Our results demonstrate both a shift in the dose response to the pneumolysin-deficient mutant and a diminished maximal response.
The marked difference between the wild-type and pneumolysin-deficient mutants suggests that changes in pneumococcal-endothelial cell interactions somehow affected by pneumolysin are also critical for recruitment of PMN and hence the intensity of the inflammatory response. It is not completely clear how the expression of pneumolysin affects pneumococcal-induced neutrophil transendothelial migration. However, our findings strongly suggest that pneumolysin does not act alone: 1) live bacteria (D39) have much greater potency than conditioned media (D39 or plnA Ϫ ) or than EtOH-fixed bacteria, and 2) conditioned media from the wild-type D39 combined with the pneumolysin-deficient organisms did not enhance migration. These data indicate that the role of pneumolysin in pneumococcal-endothelial cell interactions in our model system is not simply a result of secretion of the toxin during autolysis of the bacteria. In addition, in contrast to Fig. 9 . PMVEC surface expression of adhesion molecules. A: ICAM-1 was constitutively expressed by the endothelial monolayer and upregulated by exposure to TNF-␣, but there was no effect on surface expression in response to coincubation with D39 or plnA Ϫ (5 ϫ 10 6 CFU/ml) for 6 h. There was no expression of VCAM-1 (B) or E-selectin (C) by endothelial cells in the unstimulated monolayer, and there was no upregulation by exposure to D39 or plnA Ϫ at the abluminal surface. TNF-␣ elicited significantly increased surface expression of both molecules. ૺP Ͻ 0.05 compared with baseline expression; n ϭ 4 -6 experiments.
observations from a murine bronchopneumonia model where purified pneumolysin coinstilled into the trachea with the pneumolysin-deficient mutant restored the pattern of bacterial replication and invasion seen with the wild-type bacteria (26) , purified pneumolysin was highly toxic to the endothelium and elicited reduced levels of neutrophil migration. Together, these findings suggest a more complex interaction between the pneumococcus, the endothelial cell, and the PMN and suggest that the greater ability of the wild-type strain to elicit neutrophil migration might result from direct interaction of the bacteria with the endothelium and local delivery of specific pneumococcal products (e.g., pneumolysin).
Pneumolysin has been demonstrated to be required for normal adherence to respiratory epithelium using both an intact animal model and an organ culture model (21, 26) . The requirement for pneumolysin in pneumococcal attachment/ invasion of the pulmonary endothelium has not been studied and could potentially explain the reduced ability of the pneumolysin-deficient mutant to activate the endothelium for neutrophil migration. In our analysis of bacterial translocation across the endothelium, both strains moved from the luminal to abluminal surface within 1 h of infection at similar levels, and the only apparent difference in translocation occurred at the 6-h time point. Our data do not exclude differences in invasion of the cells of the monolayer as the monolayer was not lysed during this assay; however, it appears that the pneumolysindeficient mutant is able to attach to and move across the microvascular endothelial cell monolayer. Although our data suggest that pneumolysin is not required for attachment to the endothelial monolayer, there may be significant alterations in the receptors engaged and/or the signaling initiated in the absence of pneumolysin. In addition, our model system was designed to specifically explore a role for the pulmonary endothelium in pneumococcus-induced transmigration; hence, the epithelium is not present. This reduction in complexity is also a limitation of our in vitro model, as secreted products from the alveolar epithelium and interstitium would certainly be modifiers of the endothelial cell response to S. pneumoniae.
The molecular participants involved in pneumococcal-endothelial cell interactions are likely highly complex and may employ multiple diverse endothelial cell surface receptors Recently, Toll-like receptor 4 (TLR4) was implicated as a receptor recognizing pneumolysin and TLR4 Ϫ/Ϫ macrophages demonstrated to be hyporesponsive to purified pneumolysin. (13) Although these studies focused predominantly on the role of macrophage TLR4, the data suggest that epithelial or endothelial TLR4 might also function in the recognition of S. pneumoniae. In addition, a specific role for endothelial TLR4 has been demonstrated for pulmonary neutrophil sequestration in response to LPS instillation (2) . We postulated that recognition of S. pneumoniae by the microvascular endothelial cell and subsequent activation of the endothelium might require two or more distinct receptors that act sequentially with pneumolysin signaling through TLR4 as one step in this process. We explored IL-8 secretion by the endothelium as one proinflammatory marker of TLR4-dependent cell activation and a source of neutrophil chemoattractant and hypothesized that IL-8 secretion would be markedly diminished in the supernatant of monolayers exposed to the pneumolysin-deficient mutant. Interestingly, the wild-type and pneumolysin-deficient mutants dose dependently elicited very similar levels of IL-8 production by the endothelium. These data not only suggest that pneumolysin-mediated TLR4 activation is not the primary effector of neutrophil migration but also that neutrophil migration does not occur based on a chemoattractant gradient of IL-8.
The primary endothelial receptors interacting with the intact pneumococcus in the pulmonary capillary bed have not been defined and may require pneumolysin-sufficient organisms for full activation. Interaction with the airway epithelium is mediated by pneumococcal cell surface phosphorylcholine acting as a direct ligand for the PAFR (7), which is upregulated on the epithelium in response to inflammatory stimuli. The PAFR is also widely expressed on the vascular endothelium, and in vitro studies demonstrate that virulent pneumococci adhere to brain endothelium in a PAFR-dependent manner and appear to enter these cells by receptor-mediated endocytosis (7, 25) . This receptor-ligand pairing does not require pneumolysin. Interactions between S. pneumoniae and the vascular endothelium have predominantly been studied in the context of pneumococcal meningitis. The microvascular endothelium of the brain is distinct from all other endothelium in terms of barrier function, and the pneumococcus interacts at the luminal surface. In contrast, during the onset of pneumococcal pneumonia, the organism enters the lower respiratory tract from the upper respiratory tract, and interactions between the pneumococcus and the pulmonary microvascular endothelium occur exclusively at the abluminal surface. Further investigations of pneumococcal interactions with the pulmonary microvascular endothelium, including the role of the PAFR, are needed.
The molecular determinants of neutrophil-endothelial cell interactions in response to S. pneumoniae in the lung are also not well defined. We have previously shown that a type 3 pneumococcal strain did not enhance surface expression of ICAM-1, ICAM-2, VCAM-1, or E-selectin on pulmonary microvascular endothelium. Similarly, in the present investigation, neither the wild-type (type 2 strain) D39 nor the pneumolysin-deficient mutant elicited increased expression of ICAM-1, VCAM-1, or E-selectin on the pulmonary microvascular endothelium. These data are in agreement with the published literature, which suggest that 1) ICAM-1 has no role in S. pneumoniae-induced neutrophil recruitment to the lung in a murine model (5), 2) VCAM-1 may have a minor role in movement of PMN from the vascular space to the lung, but this role likely occurs beyond the endothelium (i.e., at the epithelium or interstitium) (23, 30) , and 3) pneumococcal pneumonia induces E-selectin-independent migration of neutrophils (15) . Together with our finding that endothelial cell NF-B was not activated by S. pneumoniae, these data suggest that the molecular determinants of neutrophil transendothelial migration elicited by the pneumococcus may be unique from those defined for other gram-positive bacteria and gram-negative bacteria.
The present study demonstrates that pneumolysin is necessary to elicit neutrophil transendothelial migration and suggests that direct interaction of the pneumolysin-containing organism may be necessary in this process. Whatever precise mechanism(s), our findings indicate a novel role for pneumolysin in pneumococcus-induced migration of PMN across the pulmonary microvascular endothelium. The in vitro model described in this study should help, in the future, to better define the molecular basis of pneumococci, endothelial cells, and PMN interactions needed to induce maximal recruitment of PMN from the vascular space to the lung.
